Nanomedicine for Treatment of Lung Cancer (Q38679309)

5 September 2017

Nanomedicine for Treatment of Lung Cancer (English)

1 reference

5 September 2017

1 reference

1 reference

Sajid Hussain

1

1 reference

PubMed ID

26703803

5 September 2017

language of work or name

English

0 references

publication date

1 January 2016

1 reference

Advances in Experimental Medicine and Biology

5 September 2017

1 reference

5 September 2017

890

1 reference

5 September 2017

137-147

1 reference

Lung cancer: New biological insights and recent therapeutic advances

5 September 2017

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

European cancer mortality predictions for the year 2013.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Therapeutic strategy for postoperative recurrence in patients with non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Cisplatin nephrotoxicity: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Extending survival of stage IV non-small cell lung cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Drug delivery systems: entering the mainstream

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Antitumor activity of an epithelial cell adhesion molecule targeted nanovesicular drug delivery system

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Recent advances with liposomes as pharmaceutical carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Altering the immune response with lipid-based nanoparticles.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Nanomedicine as an emerging platform for metastatic lung cancer therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Nanocarriers as an emerging platform for cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Chemosensitization of carcinoma cells using epithelial cell adhesion molecule-targeted liposomal antisense against bcl-2/bcl-xL.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

The resurgence of platinum-based cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Renal clearance of quantum dots

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Paclitaxel drug delivery systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Liposomal paclitaxel formulations

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

A phase I clinical and pharmacokinetic study of paclitaxel liposome infused in non-small cell lung cancer patients with malignant pleural effusions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Triple-negative breast cancer: clinical features and patterns of recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Materials science. Enhancing drug function

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Therapeutic nanoparticles for drug delivery in cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Polymeric nanoparticles for drug delivery.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Polymeric nanoparticles containing taxanes enhance chemoradiotherapeutic efficacy in non-small cell lung cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

How we got here, where we are going and being a cog in something turning

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Dendritic molecular capsules for hydrophobic compounds.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Dendrimer-encapsulated camptothecins: increased solubility, cellular uptake, and cellular retention affords enhanced anticancer activity in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Biological characterization of cetuximab-conjugated gold nanoparticles in a tumor animal model

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Classification of lung cancer histology by gold nanoparticle sensors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Multifunctional mesoporous silica nanoparticles for intracellular labeling and animal magnetic resonance imaging studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Endocytosis of a single mesoporous silica nanoparticle into a human lung cancer cell observed by differential interference contrast microscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-24932-2_8

10.1007/978-3-319-24932-2_8

31 March 2020

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26703803